---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-014878"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:22:26.690014+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical grants CEO 200K and CFO 15K options at $0.53

## Summary
- CEO Brent Lucas received options for 200,000 shares; Interim CFO Robert Potashnick received 15,000 shares.
- Exercise price set at $0.53 per share (closing price on Feb 5, 2026).
- Vesting: 25% after one year, remainder pro rata over next 36 months; options expire 10 years from award date.
- Options granted under Envoy Medical's 2023 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001213900-26-014878
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/0001213900-26-014878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/ea0276618-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-014878
- JSON: https://secwatch.observer/filing/0001213900-26-014878.json
- Plain text: https://secwatch.observer/filing/0001213900-26-014878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.